Tolerability and Overall Mortality in Patients With Non-idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease Treated With Nintedanib: Real-world Evidence From a Single Specialist Centre

Authors :: P. Rivera Ortega
L. Stranks
K. Newman
T. Garfoot
H. Morris
K. Zakis
J. Swale
M. Greaves
S. Stanel
C. Avram
J. Blaikley
C. Hayton
C. Leonard
Source :: A39. MANAGEMENT OF INTERSTITIAL LUNG DISEASE AND ITS CO-MORBIDITIES.
Publication Year :: 2023
Publisher :: American Thoracic Society, 2023.

Database :: OpenAIRE
Journal :: A39. MANAGEMENT OF INTERSTITIAL LUNG DISEASE AND ITS CO-MORBIDITIES
Accession number :: edsair.doi...........3335860587b1a2ddcffd96a4a506ee2c
Full Text :: https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1522

Full Text Access

Tools